Conditional ablation of macrophages halts progression of crescentic glomerulonephritis

Jeremy S Duffield1, Peter G Tipping, Tiina Kipari

  • 1Medical Research Council Centre for Inflammation Research Medical School, University of Edinburgh, UK, and the Renal Division, Brigham & Women's Hospital, Boston, MA 02115, USA. jduffield@rics.bwh.harvard.edu

Insights

Inflammatory macrophages drive kidney damage in crescentic glomerulonephritis by promoting cell proliferation and apoptosis. Depleting these macrophages significantly improved kidney function and reduced injury, highlighting their central role in disease progression.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Macrophages are present in inflamed glomeruli and correlate with mesangial cell proliferation and apoptosis.
  • Inflammatory macrophages are implicated in progressive renal injury, particularly in crescentic glomerulonephritis (GN).

Purpose of the Study:

  • To assess the contribution of inflammatory macrophages to progressive renal injury in murine crescentic GN.
  • To investigate the role of macrophages in regulating parenchymal cell populations, proliferation, and apoptosis during GN.

Main Methods:

  • Utilized a novel transgenic mouse model (CD11b-DTR) for specific and selective ablation of tissue macrophages.
  • Administered diphtheria toxin to deplete renal inflammatory macrophages during progressive crescentic GN.
  • Conducted morphometric analysis of renal tubules and interstitium, and assessed CD4 T cell populations.

Main Results:

  • Macrophage depletion significantly reduced glomerular crescents, improved renal function, and decreased proteinuria.
  • Attenuated tubular injury, reduced tubular cell proliferation and apoptosis, and decreased interstitial fibrosis were observed.
  • Depletion of macrophages led to a decrease in interstitial myofibroblasts and CD4 T cells in the diseased kidney.

Conclusions:

  • Macrophages are key effectors in the progression of crescentic GN.
  • Macrophages regulate parenchymal cell populations by modulating both proliferation and apoptosis.
  • Targeting macrophages may represent a therapeutic strategy for crescentic GN.

Related Concept Videos